🪴 Oliver’s Note
Given the continued evolution of science funding, I revisit the topic. Recent developments include the Senate Appropriations Committee's proposed $42.7B NIH budget, a slight 1% increase that fails to counter inflation, but sharply contrasts with the White House's proposed 40% cut.

The Senate bill rejects proposed cuts to indirect costs and a major NIH reorganization, maintaining the status quo. This echoes a pattern from the first Trump administration, where repeated White House budget proposals for NIH and NCI cuts were consistently overridden by Congress. Current concerns center on whether Congress will continue to stand up for science, making the Appropriations Committee's action a positive sign.
Then again, President Trump's August 7 Executive Order on federal grant making dampens any hope that Congress may be giving. The requirement for each agency to designate a senior appointee to review funding opportunities and grant awards appears to be overt political control, undermining the expert-driven system that has fueled scientific advancements and economic growth. It also suggests that regardless of what Congress appropriates for NIH, NSF and others, the White House will decide what actually is spent and how.
The SCIMaP team's interactive visualization powerfully illustrates the impact of ongoing funding cuts, projecting both current and future losses based on existing policies. This sobering view, which transcends simplistic political divides as previously noted, allows users to examine potential effects at the county level. It is worth watching as the next fiscal year gets underway in just a few weeks on October 1st.
A recent Government Accountability Office (GAO) report (via The Hill) revealed that the Trump administration unlawfully directed the National Institutes of Health (NIH) to cancel approximately 1,800 research grants, violating the Impoundment Control Act. This finding was both sobering and heartening - that this was in fact true is sobering.
While I was still at NCI, just a few weeks ago, people would often voice the concern that they were being made party to something illegal. We were told the President can set priorities, including what gets funded, and while this is of course true, it does not absolve him of the responsibility to assert his priorities lawfully, and respecting Congress’ responsibilities.
Heartening is that these findings can still see the light of day. GAO findings are not legally binding, but may influence congressional actions and raise concerns over the future of medical research funding amidst ongoing political pressures. Of course, they may also lead the firing of people who wrote this report…
Meanwhile, 15% budget cuts loom in Canada, across most government departments raising alarms among scientists and university groups who argue that trimming research funding would undermine the country’s long-term competitiveness and contradict the government’s stated emphasis on investing in the future.
If you want to get active and involved what better way than to connect with and support to Stand Up for Science who are currently holding 31-days of action for science.

🗓️ Upcoming Events and Deadlines
Standard NIH Due Dates
For new R01 submissions these are Feb 5, June 5, Oct 5
For R01 renewal, resubmission or revisions these are Mar 5, July 5, Nov 5
For more information check out the NIH Standard Due Dates page.
🔦 Grant Focus
NIH
Keep an eye out for the new Academic Career Excellence (ACE) Award (K32).
The K32 award supports individual postdoctoral research training to broaden scientific expertise and enhance research potential in health-related fields. Eligibility extends to candidates within 12 months prior to, or within the first two years of, their postdoctoral appointment. The award provides up to three years of mentored support, and is designed to lead into competition for the K99/R00.
There is no Notice of Funding Opportunity yet for this award, but hopefully it will be published in the coming weeks. You can review the Activity Code information here.
currently no citizenship requirement, but this may change when the NOFO is published
Standard K series due dates
TBD
NIH
Outside of NIH
The Rising Tide Foundation for Clinical Cancer Research and the Kidney Cancer Association are partnering to issue a Request for Applications (RFA) to support clinical validation studies or early stages interventional clinical trials aimed at improving the Early Detection and Diagnosis of Kidney Cancer.
eligibility - contact Program Manager (see link)
Letter of Intent due by October 15, 2025
up to $150,000 over up to 2 years
🦋 Growth Mindset

As my coaching practice grows, I frequently discuss what coaching entails with potential clients.
Unlike consulting, mentoring, or therapy, coaching is a collaborative, action-oriented process focused on driving positive change in the client's future. Crucially, coaches avoid offering personal experiences or direct advice.
Where a mentor shares relevant experiences and lessons learned, and a consultant recommends specific actions, a coach helps clients explore, gain awareness, identify obstacles, and reframe perspectives.
Becoming a coach is requiring me to "unlearn" some established behaviors, a challenging yet liberating process. Holding back, collaborating and then witnessing a client's energized shift in perspective is the most rewarding e.
🏆 Success Tools
OpenAI CEO Sam Altman recently warned against using ChatGPT as a life coach or even therapist.
The primary reason is that chatbots pose significant privacy risks due to the absence of legal confidentiality.
Altman emphasized that unlike traditional coaches or therapists, who are bound by confidentiality rules, conversations with AI do not enjoy the such protections.

This gap in privacy should deter users from adopting AI for sensitive discussions, especially as companies like OpenAI grapple with legal demands for user data and frankly don’t exactly have a sparkling track record of respecting boundaries.
So, for now, humans still have the edge when it comes to taking care of other humans. #coachedbyhumans
🗞️ Science & Policy Updates
Kennedy Cancels mRNA Vaccine Contracts
Health Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in contracts for developing mRNA vaccines, acording to an August 5th story in the New York Times (full access gift link). This targets the most agile vaccine technology capable of producing immunizations in weeks rather than months, and so represents a significant setback for pandemic preparedness as well as vaccine research. As detailed by user chrisdh79 on Reddit’s r/inthenews this was roundly criticized on social, but to what effect is unclear. Time for the private sector to step up. (Worried about vaccines more broadly, with the fall just ahead? I recommend reading this post from the Your Local Epidemiologist newsletter.)
If you are a voter in the US, please consider a visit to the AACR’s Legislative Action Center where your voice matters. They make it very easy to send email to your Congressional team.
Book a meeting via my website www.bogler.cc
Send an email to me at: [email protected]